Clinical Epidemiology and Global Health (Mar 2022)
Reply in response to the article neglecting Borderline HbA2 (3.2–3.9%) may impede prevention program for thalassemia
Abstract
No abstracts available.
Clinical Epidemiology and Global Health (Mar 2022)